As global funding for HIV continues to face significant setbacks due to reduced international aids from donor countries, ...

The report emphasises the urgent need for countries to implement radical changes in their HIV programming and funding ...

The Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

The Retention Riddle: Tackling the Toughest Barrier to Ending HIV: This session will explore proven strategies for ensuring people living with HIV stay connected to care and treatment services, a ...